您的位置: 首页 > 农业专利 > 详情页

Novel phenylaminopyrimidine derivatives as inhibitors of BCR-ABL kinase
专利权人:
Natco Pharma Limited
发明人:
Kompella, Amala,Bhujanga Rao, Adibhatla Kali Satya,Srinivas, Rachakonda,Khadgapathi, Podili,Nannapaneni, Venkaiah Chowdary
申请号:
AU2005281299
公开号:
AU2005281299B2
申请日:
2005.07.19
申请国别(地区):
AU
年份:
2012
代理人:
摘要:
The present invention relates to novel intermediates useful for the preparation of novel phenylaminopyrimidine derivatives, novel phenylaminopyrimidine derivatives. Pharmaceutical composition containing the novel phenylaminopyrimidine derivatives and processes for their preparation. The invention particularly relates to novel Phenyl pyrimidine amine derivatives of the general formula (I). The novel compounds of the formula 1 can be used in the therapy of Chronic Myeloid Leukemia (CML). Since the IC; 191 values of these molecules are in the range 0.1 to 10.0 nm, these novel compounds are potentially useful for the treatment of CML.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充